NCT07212595View on ClinicalTrials.gov

Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Kidney InjuryMechanical Ventilation
Interventions
DRUG

Amino Acid infusion

Amino acid infusion of 2 grams/kilogram of participant weight/day for up to 72 hours

DRUG

Lactated ringers solution

Placebo infusion to match the volume of the amino acid infusion in grams/kilogram/day

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Congenital Heart Alliance of Cincinnati

UNKNOWN

lead

Stuart Goldstein, MD

OTHER

NCT07212595 - Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy | Biotech Hunter | Biotech Hunter